Laboratory Of Stock Performance
| LH Stock | USD 207.97 4.90 2.41% |
The company secures a Beta (Market Risk) of 0.93, which conveys possible diversification benefits within a given portfolio. Laboratory returns are very sensitive to returns on the market. As the market goes up or down, Laboratory is expected to follow. Laboratory has an expected return of -0.14%. Please make sure to verify Laboratory of maximum drawdown, and the relationship between the information ratio and accumulation distribution , to decide if Laboratory performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Laboratory of has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 2.49 | Five Day Return 4.3 | Year To Date Return (10.51) | Ten Year Return 142.63 | All Time Return 742.61 |
Forward Dividend Yield 0.0142 | Payout Ratio 0.1943 | Last Split Factor 1164:1000 | Forward Dividend Rate 2.88 | Dividend Date 2024-06-12 |
1 | Exercise or conversion by Peter Wilkinson of 131 shares of Laboratory subject to Rule 16b-3 | 02/06/2024 |
2 | Payment of tradable shares by Peter Wilkinson of Laboratory subject to Rule 16b-3 | 02/13/2024 |
3 | Laboratory Corporation of America Holdings Full Year 2023 Earnings EPS Misses Expectations | 03/01/2024 |
4 | LH or COO Which Is the Better Value Stock Right Now | 03/12/2024 |
| Laboratory dividend paid on 13th of March 2024 | 03/13/2024 |
5 | OPKO Health stock gains as Labcorp to buy selects for 238M | 03/28/2024 |
6 | Insider Sell EVP, President Diagnostics COO Mark Schroeder Sells Shares of Laboratory ... | 04/03/2024 |
7 | Labcorp Launches Labcorp Plasma Detect Extending Leadership into Molecular Residual Disease Clinical Research | 04/05/2024 |
8 | Labcorp Extends MRD Clinical Research With New Launch | 04/08/2024 |
9 | Labcorp wins FDA emergency nod for monkeypox test | 04/10/2024 |
10 | Myriad Genetics Announces Favorable Research Results | 04/11/2024 |
11 | Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw | 04/15/2024 |
12 | Should Value Investors Buy Labcorp Stock | 04/17/2024 |
13 | 5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings | 04/19/2024 |
14 | Exploring Analyst Estimates for Labcorp Q1 Earnings, Beyond Revenue and EPS | 04/22/2024 |
| Begin Period Cash Flow | 320.6 M |
Laboratory |
Laboratory Relative Risk vs. Return Landscape
If you would invest 22,262 in Laboratory of on January 24, 2024 and sell it today you would lose (1,955) from holding Laboratory of or give up 8.78% of portfolio value over 90 days. Laboratory of is generating negative expected returns and assumes 1.0857% volatility on return distribution over the 90 days horizon. Put differently, 9% of stocks are less risky than Laboratory on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Laboratory Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratory's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratory of, and traders can use it to determine the average amount a Laboratory's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1289
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LH |
Estimated Market Risk
| 1.09 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Laboratory is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratory by adding Laboratory to a well-diversified portfolio.
Laboratory Fundamentals Growth
Laboratory Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratory, and Laboratory fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratory Stock performance.
| Return On Equity | 0.0423 | ||||
| Return On Asset | 0.0377 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 22.51 B | ||||
| Shares Outstanding | 84.13 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.20 X | ||||
| Price To Sales | 1.42 X | ||||
| Revenue | 12.16 B | ||||
| Gross Profit | 4.39 B | ||||
| EBITDA | 1.7 B | ||||
| Net Income | 379.2 M | ||||
| Cash And Equivalents | 430 M | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 5.95 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 93.86 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Earnings Per Share | 4.33 X | ||||
| Market Capitalization | 17.08 B | ||||
| Total Asset | 16.73 B | ||||
| Retained Earnings | 7.89 B | ||||
| Working Capital | 540.2 M | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
About Laboratory Performance
To evaluate Laboratory Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Laboratory generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Laboratory Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Laboratory market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Laboratory's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 19.21 | 10.42 | |
| Return On Tangible Assets | 0.06 | 0.05 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.05 |
Things to note about Laboratory performance evaluation
Checking the ongoing alerts about Laboratory for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratory help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Laboratory generated a negative expected return over the last 90 days | |
| Laboratory has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 13th of March 2024 Laboratory paid $ 0.72 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Exploring Analyst Estimates for Labcorp Q1 Earnings, Beyond Revenue and EPS |
- Analyzing Laboratory's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratory's stock is overvalued or undervalued compared to its peers.
- Examining Laboratory's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratory's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratory's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratory's stock. These opinions can provide insight into Laboratory's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.46) | Dividend Share 2.88 | Earnings Share 4.33 | Revenue Per Share 139.628 | Quarterly Revenue Growth 0.035 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.